Advitech and Natunola Announce Anticipated Closing Date for Their Merger

Advitech Inc. ("Advitech" or the "Corporation") (TSX VENTURE:AVI) and Natunola
Health Biosciences Inc. ("Natunola") (TSX VENTURE:NHI) are pleased to announce
that all conditions precedent for the completion of their proposed merger
transaction (the "Transaction") under the terms of the merger agreement entered
into between Advitech and Natunola on June 29, 2011, including closing of a
private placement with minimum aggregate gross proceeds of at least $3,500,000
are currently expected to be fulfilled on or around October 7, 2011 since
confirmations of subscriptions totalling at least $3,500,000, the minimum amount
required to complete the concurrent private placement, have been received.
Advitech and Natunola therefore anticipate completion of the Transaction on or
around that date subject to the satisfaction of all necessary regulatory
approvals and other closing conditions. 


About Advitech Inc.:

Advitech, which includes its subsidiary Botaneco Specialty Ingredients Inc.
since November 20, 2009, is a health sciences and technology company developing,
manufacturing and marketing proprietary natural ingredients and formulations for
oral and topical applications that have been clinically proven to be safe and
effective for improving skin health and well being. More information is
available and can be accessed at www.advitech.com 


About Natunola Health Biosciences Inc.:

Natunola and its manufacturing plant are located in Winchester, Ontario.
Natunola is a manufacturer and researcher in the field of flax seed derived
omega -3 fatty acids, flax protein, flax lignans, specialty natural products,
bio-nutrients and functional supplements for human and animal care markets.
Natunola also produces canola oil gels and other natural ingredients for the
cosmetic and personal care industry. Natunola has a retail health product line
under the brand name of Natunola(R) Health's Delight. Natunola was the winner
for the National Canadian Agri-Food Award of Excellence for Innovation for the
year 2008. www.natunola.com


Cautionary Statements:

This news release contains forward-looking statements and information ("forward
looking statements") within the meaning of applicable securities laws relating
to the proposal to complete the proposed plan of arrangement and associated
transactions (including the private placement financing), including statements
regarding the terms and conditions of the proposed plan of arrangement and
associated transaction. Readers are cautioned to not place undue reliance on
forward-looking statements. Actual results and developments may differ
materially from those contemplated by these statements depending on, among other
things, the risks that the parties will not proceed with the proposed
amalgamation and associated transactions, that the ultimate terms of the
proposed amalgamation and associated transactions will differ from those that
currently are contemplated, and that the proposed amalgamation and associated
transactions will not be successfully completed for any reason (including the
failure to obtain the required approvals or clearances from regulatory
authorities or to complete the concurrent financing). Furthermore, the
forward-looking statements contained in this document are made as of the date of
this document and, except as required by applicable law neither Advitech nor
Natunola undertakes any obligation to publicly update or to revise any of the
included forward-looking statements, whether as a result of new information,
future events or otherwise. The forward-looking statements contained in this
document are expressly qualified by this cautionary statement.

Natunola Health Biosciences In (TSXV:NHI)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024